Contact NanoOnco
Please contact us to learn more about the NanoOnco Anti-Cancer concept.
Our Solution
A unique BioMg 250 implant is in development with the University of Michigan/US Veterans Administration/NanoOnco team to deliver anti-cancer treatment into the tumor, reducing harmful effects on the body. The novel BioMg 250 wire is one part of a 3 part system that also includes a novel insertion device and an ultrasound device to monitor placement of wires in a tumor.
| Number of BioMg 250 Wires | Lung Cancer Cell Count (105) |
|---|---|
| 0 | 2.35 |
| 1 | 1.65 |
| 3 | 0.45 |
Increased BioMg 250 Boosts Lung Cancer Cell Killing (4 Days In Vitro)
D. Nagrath & S. Ejike – Sponsored by Michigan Materials Research Institute & NanoOnco, Inc
| Combination | Lung Cancer Cell Count (105) (p=0.001%) |
|---|---|
| 1 Bare BioMg 250 Wire | 1.65 |
| 1 BioMg 250 Wire with 10 µg* Cisplatin Coating | 0.70 |
| 1 BioMg 250 Wire with 20 µg* Cisplatin Coating | 0.60 |
* Cisplatin loading is 0.001% of Normal Chemotherapy IV Whole Body Treatments
D. Nagrath & S. Ejike – Sponsored by Michigan Materials Research Institute & NanoOnco

